Humanigen Inc

NASDAQ:HGEN   3:59:56 PM EDT
0.16
0.00 (+0.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.07M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.26 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$0.18
50-Day MA$0.30
200-Day MA$2.00
See more pivots

Humanigen Inc Stock, NASDAQ:HGEN

830 Morris Turnpike, 4th floor, Essex County, New Jersey 07078
United States of America
Phone: +1.973.200.3100
Number of Employees: 11

Description

Humanigen, Inc. is a clinical-stage biopharmaceutical company. engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Essex County, NJ.